UNSPSC 51263304: Butocrolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C19H23NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F63SY70KV0, chemically known as 9-(3-(tert-butylamino)-2-hydroxypropoxyl)-4-hydroxy-7-methyl-5h-furo(3,2-g)(1)benzopyran-5-one. but generally known as butocrolol, which bears US NIH Compound Identifier 189906. European Medicines Agency schedules Butocrolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06027MIG.

UNSPSC 51263304 Butocrolol, a Commodity code, shows minimal recent state and local procurement activity directly aligned with the code's nominal scope. The two most recent opportunities posted under this code — a Seminole County, Florida IFB for naloxone and drug deactivation systems (due July 26, 2023) and a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs (due April 3, 2026) — do not represent purchases of butocrolol itself. The naloxone procurement targets opioid-overdose response supplies for community health delivery, while the Texas RFI solicits vendor capabilities for pharmacy benefit program restructuring. Neither opportunity reflects actual demand for butocrolol as a pharmaceutical product or intermediate. State and local issuers tagging opportunities under this code appear to be using it as a catch-all for pharmaceutical or health-supply procurement rather than purchasing the specific active pharmaceutical ingredient or formulation the code nominally describes.

The geographic activity shown in recent postings spans Florida and Texas, but the mismatch between the code's nominal scope and the actual work being solicited suggests either data-classification error in the source system or a jurisdiction's broad interpretation of the code's boundaries. Business development professionals evaluating this code should verify directly with issuing bodies how they apply it to their procurement categories and flag the classification discrepancy with source data owners. The code does not demonstrate consistent, targeted procurement activity that would support a focused pursuit strategy at this time.